Global Tumor Biomarker Test Kits Market: Growth Drivers, Segment Analysis & Future Outlook (2023–2030)
The Global Tumor Biomarker Test Kits Market , valued at USD 13.1 billion in 2022 , is projected to reach USD 29.76 billion by 2030 , growing at an impressive CAGR of 10.8% during the forecast period (2023–2030). Tumor biomarker test kits play a crucial role in the early detection, monitoring, and personalized treatment of cancers, making them an indispensable component of modern healthcare systems. Understanding Tumor Biomarker Test Kits Biomarkers are biological indicators that reveal the presence or progression of disease. Tumor biomarker test kits detect changes in: Genes Proteins Other biological molecules These kits enable early detection of cancer, monitoring of disease progression, and evaluation of treatment efficiency. When paired with targeted therapies, these tests are often referred to as companion diagnostics , forming a key pillar of precision medicine . Download Sample Market Growth Drivers 1. Rising Global Cancer Prevalence The increas...